Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

1 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

8(80.0%)

Phase 4

1(10.0%)

Phase 1

1(10.0%)

10Total

N/A(8)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT04745962Completed

Thin EBUS Pilot Study

Role: collaborator

NCT04055688Completed

Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas

Role: collaborator

NCT04937244Phase 4Unknown

Pilot Study Evaluating the Optimization of the ORBEYE Blue Light Filter During Fluorescence-Guided Resection of Gliomas

Role: collaborator

NCT02470052Not ApplicableTerminated

A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe Emphysema

Role: lead

NCT01555840Not ApplicableCompleted

Comparative Study of the Magnetically Guided Capsule Endoscopy Versus High Definition Gastroscopy

Role: collaborator

NCT02442830Not ApplicableCompleted

Comparing Early Capsule Deployment to Current Standard of Care for Management of Gastrointestinal Bleeding

Role: collaborator

NCT02592837Not ApplicableCompleted

EBUS-TBNA vs Flex 19G EBUS-TBNA

Role: collaborator

NCT01989182Not ApplicableCompleted

The Spiration Valve System for the Treatment of Severe Emphysema

Role: collaborator

NCT02156557Phase 1Completed

Study of KCC Peptide Application in the Colon

Role: collaborator

NCT01753479Not ApplicableCompleted

Spectroscopy From Duodenum

Role: lead

NCT02916459Not ApplicableUnknown

EBUS-TBNA vs Flex 19G EBUS-TBNA

Role: collaborator

NCT01699698Not ApplicableCompleted

Pancreatic Juice Diagnosis From Duodenum

Role: lead

All 12 trials loaded